Diabetes Research and Training Center

糖尿病研究与培训中心

• 批准号: 7908051
• 负责人: FREDRIC E. WONDISFORD
• 金额: $ 27.7万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-25 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7908051
• 关键词: Appointment; Baltimore; Basic Science; Biomedical Research; Budgets; Caring; Cities; Clinical; Clinical Research; Collaborations; Communication; Complications of Diabetes Mellitus; Diabetes Mellitus; Diagnosis; Discipline of Nursing; Education; Effectiveness; Endocrine System Diseases; Endocrinology; Environment; Epidemiology; Faculty; Feeding behaviors; Fostering; Funding; Genetic; Genetic Research; Goals; Health Professional; Healthcare; Human Resources; Individual; Institution; Insulin; Laboratories; Maryland; Neurosecretory Systems; Nursing Faculty; Nutritionist; Obesity; Operative Surgical Procedures; Participant; Patients; Persons; Physicians; Play; Populations at Risk; Productivity; Program Description; Public Health Schools; Recruitment Activity; Research; Research Activity; Research Personnel; Research Project Grants; Research Training; Resources; Role; Schools; Scientist; Speed; Talents; Training Activity; Training Programs; Translations; Underserved Population; United States; United States National Institutes of Health; Universities; adipocyte biology; base; cost effective; diabetes management; diabetic; interest; medical schools; member; multidisciplinary; outreach; programs; response; translational study

This proposal seeks new funding for a Baltimore Diabetes Research and Training Center (DRTC). The proposed Center will involve investigators from Johns Hopkins University and the University of Maryland. These investigators have primary appointments in numerous departments within and between these Institutions; and while their scientific backgrounds are diverse, they share a common interest in diabetes and endocrinology research and many have established collaborations. The aims of the Center are the following: 1) to foster collaborative, multidisciplinary diabetes and endocrinology research in a supportive environment; 2) to enhance the clinical and basic research capabilities of established diabetes investigators; 3) to encourage investigators not involved in diabetes research to become interested in pursuing problems related to diabetes and endocrinology; 4) to develop and implement programs for the training of health care professionals in the diagnosis and management of diabetes; 5) to develop, implement and evaluate programs that deliver cost effective health care for the treatment of persons with diabetes; 6) to speed the translation of advances in basic biomedical and genetic research to the clinical arena where they may be applied to!the diagnosis and treatment of persons with diabetes; and 7) to inform others in both professional and lay settings of the accomplishments, opportunities and advancements in diabetes research and training. This application contains four separate components: Administrative, Biomedical Research, and Pilot and Feasibility and Enrichment. The Administrative Component will be responsible for overseeing the operation of the Center as a whole. The Biomedical Research Component will consist of six Core Laboratories to foster collaborative diabetes research. A Pilot and Feasibility Component will foster the participation and interaction of junior investigators with established investigators in research related to diabetes. The Enrichment Program will facilitate the interaction within and between Johns Hopkins University and the University of Maryland. Since these Institutions have complementary research interests, the Enrichment Program as well as the proposed Biomedical Research Cores will strengthen collaborative ties between the Institutions. Taken together, these objectives and components define the new Baltimore Diabetes Research and Training Center (DRTC).

该提案为巴尔的摩糖尿病研究和培训中心（DRTC）寻求新的资金。 拟议中的中心将涉及来自约翰霍普金斯大学和密歇根大学的研究人员。 马里兰州。这些调查员在许多部门内部和之间有主要任命 这些机构;虽然他们的科学背景是不同的，他们有共同的利益， 糖尿病和内分泌学研究，许多人建立了合作关系。该中心的目标是 以下内容：1）促进合作，多学科的糖尿病和内分泌学研究， 2）加强糖尿病研究者的临床和基础研究能力; 3)鼓励未参与糖尿病研究的研究人员对追求问题感兴趣 与糖尿病和内分泌学有关的; 4）制定和实施保健培训计划 糖尿病的诊断和管理专业人员; 5）制定，实施和评估 为糖尿病患者的治疗提供具有成本效益的医疗保健的计划; 6）加快 将基础生物医学和遗传学研究的进展转化为临床竞技场， 适用于！糖尿病患者的诊断和治疗;以及7）在专业和专业方面告知他人 并奠定了在糖尿病研究和培训的成就，机会和进步的背景。 此应用程序包含四个独立的组件：管理、生物医学研究和试点 可行性和丰富性。行政部门将负责监督 整个中心的运作。生物医学研究部分将包括六个核心 实验室促进糖尿病合作研究。试点和可行性部分将促进 初级研究者与资深研究者在研究中的参与和互动， 糖尿病丰富计划将促进约翰霍普金斯内部和之间的互动 大学和马里兰州大学。由于这些机构的研究兴趣互补， “浓缩计划”和拟议中的“生物医学研究核心”将加强合作， 机构之间的联系。这些目标和要素共同定义了新的巴尔的摩 糖尿病研究和培训中心（DRTC）。